Twitter | Search | |
Search Refresh
EMAS Oct 8
EMA’s safety committee (PRAC) has recommended limiting the use of high-strength creams containing 100 micrograms/gram (0.01%) of to a single treatment period of up to four weeks. European Medicines Agency via
Reply Retweet Like
JAMA Sep 25
The has approved Bijuva,a fixed-dose combo of bioidentical and , for oral treatment of mod-severe vasomotor symptoms inmenopausal women w an intact uterus
Reply Retweet Like
NAMS Oct 11
NAMS Responds to European Medicines Agency Statement on Vaginal Creams
Reply Retweet Like
Salimetrics Oct 7
Cognitive Reappraisal of Negative emotions may be related to salivary E2 and DLFPC Activity;
Reply Retweet Like
TransAdvice 19 Dec 16
In the NE USA? On inject-able ? Shortage got you down? in NYC can compound to order, and ship. Recommended
Reply Retweet Like
Am Soc Nephrology Jun 12
and help guard against disease, , and , research suggests |
Reply Retweet Like
AJP-Cell Physiology 5 Apr 18
Read all about how “Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by acting on GPER”:
Reply Retweet Like
Zoey Rose ⚧ 🌈 9 Apr 18
I want FFS for more feminine features, but also to balance out the symmetry a little more. It's like only did half my face. But it's still better than my old mug.
Reply Retweet Like
Anal Bioanal Chem 22 Sep 17
Simultaneous measurement of total and in human by HW Vesper et al
Reply Retweet Like
Zhana Vrangalova PhD 19 Jan 17
Women using w/ less (v. higher E or no-pill) are better at detecting & identifying smells.
Reply Retweet Like
Journal Sexual Med. 19 Dec 16
Men with pre-diabetes have lower and higher levels
Reply Retweet Like
SavvyDoc🇺🇸 20 Mar 17
Yes. Quite a bit on connection - worse in women with low , a hormone that IMPROVES immune function. Get tested properly.👍👍
Reply Retweet Like
Mx J. Strand McCutchen 10 Jul 18
Reply Retweet Like
Jaime Willett, PhD Nov 5
#👋🏻 ! Come talk to me and 2 other from the about how the and modulates MSN physiology at posters - this afternoon 1-5pm!
Reply Retweet Like
George Barreto Ph.D. Sep 12
Reply Retweet Like
NAMS Sep 24
A new study based on data has identified the various determinants of levels among healthy women using hormone therapy. Learn more about this research that will be presented at our Annual Meeting.
Reply Retweet Like
EU Medicines Agency Oct 4
At its October meeting, our safety committee recommended a 4-week limit for the use of high-strength creams. Access the link to see the full infographic:
Reply Retweet Like
EndocrinologyAdvisor Oct 22
Research revealed that higher levels of plasma were associated with reduced progression of in early women.
Reply Retweet Like
Viglya Oct 15
: Four-week limit for use of high-strength creams
Reply Retweet Like
HormonesMatter 27 Feb 17
Tank and Lose Metabolic Flexibility: Pitfalls of and
Reply Retweet Like